0.2700
-0.0050
(-1.82%)
At close: January 10 at 2:18:58 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
776.5170
135.9430
750.3780
3,204.6360
Operating Income
-776.5170
-135.9430
-750.3780
-3,204.6360
Net Non Operating Interest Income Expense
296.4830
241.4210
86.0380
-30.5300
Other Income Expense
--
-83.4700
-41.8660
--
Pretax Income
-3,256.0850
22.0080
-706.2060
-3,235.1660
Net Income Common Stockholders
-3,256.0850
22.0080
-706.2060
-3,235.1660
Diluted NI Available to Com Stockholders
-3,256.0850
22.0080
-706.2060
-3,235.1660
Basic EPS
-0.06
0.00
-0.01
-0.06
Diluted EPS
-0.06
0.00
-0.01
-0.06
Basic Average Shares
53,803.3550
53,753.3560
53,753.3560
53,753.3560
Diluted Average Shares
53,803.3550
53,753.3560
53,753.3560
53,753.3560
Total Expenses
776.5170
135.9430
750.3780
3,204.6360
Net Income from Continuing & Discontinued Operation
-3,256.0850
22.0080
-706.2060
-3,235.1660
Normalized Income
-3,256.3540
22.0080
-706.2060
-3,235.1660
Interest Income
369.8800
241.4210
86.0380
--
Interest Expense
--
--
20.1360
30.5300
Net Interest Income
296.4830
241.4210
86.0380
-30.5300
EBIT
-3,340.6390
-135.9430
-750.3780
-3,204.6360
EBITDA
-3,340.6390
-135.9430
-750.3780
-2,908.8280
Reconciled Depreciation
--
--
364.5520
295.8080
Net Income from Continuing Operation Net Minority Interest
-3,256.0850
22.0080
-706.2060
-3,235.1660
Total Unusual Items Excluding Goodwill
0.2690
--
--
--
Total Unusual Items
0.2690
--
--
--
Normalized EBITDA
-3,340.9080
-135.9430
-750.3780
-2,908.8280
Tax Rate for Calcs
--
0.0004
--
--
12/31/2021 - 2/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WF6.MU MindBio Therapeutics Corp
0.0104
0.00%
ARCH.V Arch Biopartners Inc.
1.9500
+1.04%
XRTX.V XORTX Therapeutics Inc.
1.8500
-5.13%
XRTX XORTX Therapeutics Inc.
1.2600
-3.08%
SVA.TO Sernova Corp.
0.2250
0.00%
COYA Coya Therapeutics, Inc.
5.77
-4.94%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
MIRM Mirum Pharmaceuticals, Inc.
41.32
-1.62%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
CYBN.NE Cybin Inc.
12.85
-7.22%